Trials / Completed
CompletedNCT01914692
Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection
Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection -a Prospective Randomized Controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- First Affiliated Hospital, Sun Yat-Sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Gastric cancer radical surgery related complications are common.Somatostatin is a conventional medical therapy for bleeding.This study explore the effect of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node dissection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somatostatin | Somatostatin is a kind of traditional medicines ,which is for the treatment of intestinal fistula，upper gastrointestinal hemorrhage. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2013-08-02
- Last updated
- 2013-08-02
Source: ClinicalTrials.gov record NCT01914692. Inclusion in this directory is not an endorsement.